Status:
COMPLETED
Efficacy and Safety of Dexmedetomidine to Bupivacaine in Supraclavicular Brachial Plexus Block
Lead Sponsor:
Kafrelsheikh University
Conditions:
Dexmedetomidine
Bupivacaine
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The study aims to evaluate the analgesic efficacy and safety of addition of 1µg/kg dexmedetomidine to 20ml bupivacaine compared to 20ml and 30ml bupivacaine without additives in ultrasound-guided supr...
Detailed Description
Dexmedetomidine, a highly selective α2 adrenergic agonist, has been used as an adjuvant to local anesthetics. Various clinical trials performed have shown dexmedetomidine to be safe when used as an ad...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologist (ASA) grade I or II patients
- both sexes
- scheduled for elective upper limb surgery below mid-humerus level under Ultrasound -guided Supraclavicular brachial plexus block .
Exclusion
- with pre-existing peripheral neuropathy of upper limb.
- Bleeding disorders.
- Infection at injection site.
- Untreated pneumothorax.
- Patients on adrenoreceptor agonist or antagonist therapy.
- History of severe cardiac,.respiratory, hepatic, or renal disease.
- pregnancy and known hypersensitivity to the study drugs.
Key Trial Info
Start Date :
October 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 11 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06020781
Start Date
October 9 2023
End Date
March 11 2024
Last Update
April 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafrelsheikh University
Kafr ash Shaykh, Kafrelsheikh, Egypt, 33516